Cryopyrin-associated periodic syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}} {{Sahar}}
{{CMG}}; {{AE}} {{Sahar}}
==Overview==
==Overview==
The exact pathogenesis of cryopyrin-associated periodic syndrome is not fully understood.
The exact pathogenesis of cryopyrin-associated periodic syndrome is not fully understood. However, it occurs due to the dysregulation of innate immune system. NLRP3 gene encoding a protein called cryopyrin involved in the pathogenesis of this disorder.  
==Pathophysiology==
==Pathophysiology==
===Physiology===
===Physiology===
Line 32: Line 32:
**Destructive arthropathy
**Destructive arthropathy
**Secondary amyloidosis
**Secondary amyloidosis
==Microscopic Pathology==
*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 21:34, 11 July 2019

Cryopyrin-associated periodic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryopyrin-associated periodic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryopyrin-associated periodic syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryopyrin-associated periodic syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryopyrin-associated periodic syndrome pathophysiology

CDC on Cryopyrin-associated periodic syndrome pathophysiology

Cryopyrin-associated periodic syndrome pathophysiology in the news

Blogs on Cryopyrin-associated periodic syndrome pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cryopyrin-associated periodic syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

The exact pathogenesis of cryopyrin-associated periodic syndrome is not fully understood. However, it occurs due to the dysregulation of innate immune system. NLRP3 gene encoding a protein called cryopyrin involved in the pathogenesis of this disorder.

Pathophysiology

Physiology

  • Inflammation is the complex immunological response of vascular tissues to harmful stimuli. Normally, it protects the organism from the injurious stimuli as well as initiates the healing process for the tissue.

Pathogenesis

  • The exact pathogenesis of the cryopyrin-associated periodic syndrome is not completely understood. However, it occurs due to the dysregulation of innate immune system.[1]
  • Mutations in the NLRP3 gene cause abnormal activation of the inflammasome, the molecular platform that plays a pivotal role in inflammation.
  • This leads to the overexpression of the key proinflammatory cytokine, interleukin (IL)-1β.
  • Excessive amounts of IL-1β triggers the uncontrolled release of inflammatory cytokines, which act synergistically with IL-1β inducing the inflammatory process. This process is mainly mediated via the recruitment and activation of neutrophils.

Genetics

  • Cryopyrin-associated periodic syndrome is transmitted in the autosomal dominant pattern.[2][3]
  • NLRP3 gene encoding a protein called cryopyrin (also known as nacht domain-, leucine-rich repeat- and pyrin domain-containing protein 3 [NALP3] or pyrin domain-containing apoptotic protease activating factor 1-like protein [PYPAF1] involved in the pathogenesis of this disorder.
  • Cryopyrin is derived from the Greek words for icy cold and fire. The recurrent episodes of this disease are usually triggered by cold.

Associated Conditions

  • Conditions associated with Familial Cold Autoinflammatory Syndrome (FCAS) include:[4]
    • Mild hearing loss
  • Conditions associated with Muckle-Wells Syndrome include:[5]
    • Hearing loss
    • Secondary amyloidosis
  • Conditions associated with Neonatal Onset Multisystem Autoinflammatory Disease (NOMID) include:[6][4]
    • Developmental delay
    • Seizure
    • Hydrocephalus
    • Chronic aseptic meningitis
    • Uveitis
    • Pericarditis
    • Destructive arthropathy
    • Secondary amyloidosis

References

  1. Hoffman, Hal M.; Simon, Anna (2009). "Recurrent febrile syndromes—what a rheumatologist needs to know". Nature Reviews Rheumatology. 5 (5): 249–256. doi:10.1038/nrrheum.2009.40. ISSN 1759-4790.
  2. Hoffman, Hal M.; Mueller, James L.; Broide, David H.; Wanderer, Alan A.; Kolodner, Richard D. (2001). "Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome". Nature Genetics. 29 (3): 301–305. doi:10.1038/ng756. ISSN 1061-4036.
  3. Manthiram, Kalpana; Zhou, Qing; Aksentijevich, Ivona; Kastner, Daniel L (2017). "The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation". Nature Immunology. 18 (8): 832–842. doi:10.1038/ni.3777. ISSN 1529-2908.
  4. 4.0 4.1 Almeida de Jesus, Adriana; Goldbach-Mansky, Raphaela (2013). "Monogenic autoinflammatory diseases: Concept and clinical manifestations". Clinical Immunology. 147 (3): 155–174. doi:10.1016/j.clim.2013.03.016. ISSN 1521-6616.
  5. Yu, Justin R.; Leslie, Kieron S. (2010). "Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response". Current Allergy and Asthma Reports. 11 (1): 12–20. doi:10.1007/s11882-010-0160-9. ISSN 1529-7322.
  6. Kim, Hanna; Montealegre Sanchez, Gina A.; Chapelle, Dawn C.; Plass, Nicole; Dwyer, Andrew; Goldbach-Mansky, Raphaela; Hill, Suvimol (2014). "A80: Skeletal Features of Neonatal-Onset Multisystem Inflammatory Disease (NOMID) on Anakinra Treatment: Long-Term Follow-up". Arthritis & Rheumatology. 66: S113–S113. doi:10.1002/art.38496. ISSN 2326-5191.

Template:WH Template:WS